The PROMID study group now reports that octreotide LAR (long-acting release) has a substantial antitumor effect, with longer progression-free survival compared with placebo in patients with well ...

The FDA declined to approve investigational octreotide (CAM2029) extended-release injection for acromegaly, said developer ...

Octreotide acetate 10mg, 20mg, 30mg; susp for IM inj after dilution; contains mannitol. Give by intragluteal IM inj. Not currently receiving octreotide: initiate therapy with immediate-release ...